As of May 29, 2025, Pfizer's stock price stands at $23.32, which is a significant drop from its all-time high of $51.62 on December 16, 2021. The current price is also below the 52-week high of $31.54 and above the 52-week low of $20.92. The average stock price for the last 52 weeks is $26.84, indicating a relatively stable trend despite the fluctuations.

The trading volume for Pfizer stock has been substantial, with 35,405,386 shares traded on May 23, 2025, according to historical data. This volume is indicative of investor interest and activity in the stock.

Recently, there have been no major announcements from Pfizer that could significantly impact the stock price. However, the company continues to be a leader in the pharmaceutical industry, with a diverse portfolio of drugs and vaccines. The ongoing development of new treatments and the company's commitment to healthcare innovation are likely to maintain investor confidence.

Major analysts have not made any significant updates or changes to their price targets for Pfizer stock recently. However, forecasts suggest that the stock could see some growth in the coming months. For example, one forecast indicates that the stock could start at $35.40 in May 2025, with a maximum of $39.00 and a minimum of $33.22, averaging at $35.93 by the end of the month[5].

In summary, while Pfizer's stock price has experienced some volatility, the company's strong position in the pharmaceutical industry and ongoing innovation efforts are likely to support its value. Investors should continue to monitor the stock for any significant updates or announcements that could impact its performance.

For more http://www.quietplease.ai

Stock up on these deals
https://amzn.to/3QFpYIX

This content was created in partnership and with the help of Artificial Intelligence AI